Apoptotic versus proliferative activities in human benign prostatic hyperplasia

Human Pathology

Volumn 27, Issue 7, 1996, Pages 668-675

  Kyprianou, N ^a   Tu, H ^a   Jacobs, S C ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

apoptosis; benign prostatic hyperplasia; cell proliferation; transforming growth factor bcl 2 expression

Indexed keywords

PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE HYPERTROPHY; REGULATORY MECHANISM;

EID: 0029899625     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90396-2     Document Type: Article

References (33)

1. PC Walsh Benign prostatic hyperplasia: Etiological considerations FA Kimball AE Buhl DE Carter Approaches to the Study of Benign Prostatic Hyperplasia 1984 Liss New York, NY 10 25
2. JD McDonnell Medical management of BPH with androgen suppression The Prostate 3 1990 49 59 (suppl)
3. SJ Berry DS Coffey PC Walsh The development of human benign prostatic hyperplasia with age J Urol 132 1984 474 479
4. JT Isaacs Control of cell proliferation and cell death in the normal and neoplastic prostate: A stem cell model ed 4 CH Rodgers DS Coffey G Cunha Benign Prostatic Hyperplasia vol 2 1985 NIH Bethesda, MD 85 94 (Publication No 87-2881)
5. JA Meyers G Sufrin SA Maring Proliferation activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling J Urol 128 1982 1353 1356
6. S Claus M Wrenger T Senge Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates Urol Res 21 1993 305 308
7. MPW Gallee E Visser-De Jong FJW Ten Kate Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostate cancer J Urol 142 1989 1342 1346
8. WA Sakr FH Sarkar P Sreepaths Measurement of cellular proliferation in human prostate by Agnor, PCNA and SPF The Prostate 22 1993 147 154
9. S Tunn R Nass S Ekkernkamp Evaluation of average life span of epithelial and stromal cells of human prostate by superoxide dismutase activity The Prostate 15 1989 263 271
10. MC Raff Social controls on cell survival and cell death Nature 256 1992 396 400
11. MJ Arrends AH Wyllie Apoptosis: Mechanisms and roles in pathology Int Rev Exp Pathol 32 1991 233 250
12. N Kyprianou JT Isaacs Activation of programmed cell death in the rat ventral prostate after castration Endocrinology 122 1988 552 562
13. HF English N Kyprianou JT Isaacs Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration The Prostate 15 1989 233 251
14. J Massague The transforming growth factor-β family Annu Rev Cell Biol 6 1990 597 641
15. N Kyprianou JT Isaacs Expression of transforming growth factor-β in rat ventral prostate during castration-induced programmed cell death Mol Endocrinol 3 1989 1515 1522
16. 1 in cultured uterine epithelial cells ed 4 Proc Natl Acad Sci U S A 88 1991 3412 3415
17. K Yanagihara M Tsumuraya Transforming growth factor β induces apoptotic cell death in cultured human gastric carcinoma cells Cancer Res 52 1992 4042 4045
18. 1 on proliferation and death of rat prostatic cells Endocrinology 127 1990 2963 2968
19. JC Reed BCL-2 and the regulation of programmed cell death J Cell Biol 1214 1994 1 6
20. DM Hockenberry M Zutler N Hickey bcl-2 protein is topographically restricted in tissue characterized by apoptotic cell death ed 4 Proc Natl Acad Sci U S A 88 1991 6961 6965
21. T McDonnell P Troncoso SM Brisbay Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer Cancer Res 52 1992 6940 6944
22. MB Brronner C Culin JC Reed The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model Am J Pathol 146 1995 20 26
23. 1 and bcl-2 expression Int J Cancer 1996 (in press)
24. Y Gavrieli Y Sherman SA Ben-Sasson Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 119 1992 493 501
25. JH Wijsman RR Jonker R Keiger A new method to detect apoptosis in paraffin sections: In situ end labeling of fragmented DNA J Histochem 41 1993 7 12
26. G Cattoretti MH Becker G Key Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1) and (MIB3) detect proliferation cells in microwave processed formalin fixed paraffin sections J Pathol 168 1992 357 363
27. S Krajewski S Tanaka S Takayama Investigations of the subcellular distriution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes Cancer Res 53 1993 4701 4714
28. DM Sutkowski C-J Fong JA Sensibar Interaction of epidermal growth factor and transforming growth factor β in human prostatic epithelial cells in culture The Prostate 21 1992 133 143
29. E Glynne-Jones ME Harper L Goddard Transforming growth factor beta 1 expression in benign and malignant prostatic tumors The Prostate 25 1994 210 218
30. S Eklov K Funa H Nordgen Lack of the latent transforming growth factor β binding protein in a malignant but not benign prostatic tissue Cancer Res 53 1993 3193 3197
31. RR Berges J Vukanovic JI Epstein Implication of cell kinetic changes during the progression of human prostate cancer Clinical Cancer Res 1 1995 473 480
32. S Krajewski M Krajewska M Shabaik Immunohistochemical analysis of in vivo patterns of bcl-X expression Cancer Res 54 1994 5501 5507
33. E Wang Senescent human fibroblasts resist programmed cell death and failure to suppress bcl-2 is involved Cancer Res 55 1995 2284 2292